Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Should secondary pharmacogenomic variants be actively screened and reported when diagnostic genome-wide sequencing is performed in a child?

23 Nov 2023

Abstract excerpt

This white paper was prepared by the Global Alliance for Genomics and Health Regulatory and Ethics Work Stream's Pediatric Task Team to review and provide perspective with respect to ethical, legal, and social issues regarding the return of secondary pharmacogenomic variants in children who have a serious disease or developmental disorder and are undergoing exome or genome sequencing to identify a genetic cause...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genomics and Rare Diseases
Share to Pharmaceutical studies and practices
Share to Pharmacogenetics and Drug Metabolism

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38007624
DOI: 10.1016/j.gim.2023.101033

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Should secondary pharmacogenomic variants be actively screened and reported when diagnostic genome-wide sequencing is performed in a child?PMID 38007624Read ↗

Disclosure of Incidental Findings From Next-Generation Sequencing in Pediatric Genomic ResearchSemantic proximity Read ↗

Large-scale evaluation of outcomes following a genetic diagnosis in children with severe developmental disordersSemantic proximity Read ↗

Professionally Responsible Disclosure of Genomic Sequencing Results in Pediatric PracticeSemantic proximity Read ↗

Genomic sequencing identifies secondary findings in a cohort of parent study participantsSemantic proximity Read ↗

Ethical issues in pediatric genetic testing and screeningSemantic proximity Read ↗

Paediatric genomics: diagnosing rare disease in children.Semantic proximity Read ↗

An approach to pediatric exome and genome sequencingSemantic proximity Read ↗

Genomic sequencing identifies secondary findings in a cohort of parent study participants.Semantic proximity Read ↗

The Challenge of Analyzing the Results of Next-Generation Sequencing in Children.Semantic proximity Read ↗

Secondary findings in pediatric genomic testing: clinical insights from Turkey.Semantic proximity Read ↗

An algorithm to identify patients with rare genetic disorders and its real-world data applicationSemantic proximity Read ↗

Predictive genetic testing for adult‐onset disorders in minors: a critical analysis of the arguments for and against the 2013 ACMG guidelinesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.